DV
Dividend Vision

CNTB — Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Ltd (CNTB)

Total return is -86.2% over the past 5.4 years, 200.2 points behind SPY at 114.0%. Its deepest 1-year drawdown was 46.6%.

Connect Biopharma Holdings Ltd is an equity stock that focuses on the biopharmaceutical sector, with inception dating to March 2021. The fund does not currently offer a dividend distribution or yield profile, making it oriented toward capital appreciation rather than income generation. This stock appeals primarily to growth-oriented investors seeking exposure to the biotechnology and pharmaceutical development space rather than those prioritizing regular dividend income.

CNTB key facts

Asset type
Stock
Asset class
Equity
Inception date
03/19/2021
Last close
$2.55
Market cap
$149,853,968
Average volume
212200.0
Beta
-0.183
Payout ratio
0.0
Forward P/E
0.7669
EPS
$-1.15